Overview

Psilocybin-Enhanced Psychotherapy for Methamphetamine Use Disorder

Status:
Not yet recruiting
Trial end date:
2024-06-30
Target enrollment:
Participant gender:
Summary
This is a proof-of-concept randomized clinical trial of psilocybin-enhanced psychotherapy versus treatment-as-usual among individuals being treated for methamphetamine use disorder.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Portland VA Research Foundation, Inc
Collaborator:
Steven and Alexandra Cohen Foundation
Treatments:
Psilocybin